Pharmagreen Biotech (Pharmagreen Biotech) Effective Interest Rate on Debt % : 20.15% (As of Jun. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Pharmagreen Biotech Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Pharmagreen Biotech's annualized positive value of Interest Expense for the quarter that ended in Jun. 2023 was $0.08 Mil. Pharmagreen Biotech's average total debt for the quarter that ended in Jun. 2023 was $0.40 Mil. Therefore, Pharmagreen Biotech's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2023 was 20.15%.

Pharmagreen Biotech Effective Interest Rate on Debt % Historical Data

The historical data trend for Pharmagreen Biotech's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagreen Biotech Effective Interest Rate on Debt % Chart

Pharmagreen Biotech Annual Data

Trend

Apr08

Apr09

Sep18

Sep19

Sep20

Sep21

Sep22

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

200.00

12.82

169.91

156.30

15.46

Pharmagreen Biotech Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															20.03	5.51	20.71	51.65	20.15

Competitive Comparison of Pharmagreen Biotech's Effective Interest Rate on Debt %

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmagreen Biotech's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Pharmagreen Biotech's Effective Interest Rate on Debt % falls into.

Pharmagreen Biotech Effective Interest Rate on Debt % Calculation

Pharmagreen Biotech's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Sep. 2022 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Sep. 2021 )	+	Total Debt (A: Sep. 2022 ))	/ count )
=	-1 * -0.047	/	( (0.27	+	0.338)	/ 2 )
=	-1 * -0.047	/	0.304
=	15.46 %

where

	Total Debt (A: Sep. 2021 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.039	+	0.231
=	0.27

	Total Debt (A: Sep. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.119	+	0.219
=	0.338

Pharmagreen Biotech's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Mar. 2023 )	+	Total Debt (Q: Jun. 2023 ))	/ count )
=	-1 * -0.08	/	( (0.394	+	0.4)	/ 2 )
=	-1 * -0.08	/	0.397
=	20.15 %

where

	Total Debt (Q: Mar. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.091	+	0.303
=	0.394

	Total Debt (Q: Jun. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.12	+	0.28
=	0.4

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Jun. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Pharmagreen Biotech (OTCPK:PHBI) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Pharmagreen Biotech Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Pharmagreen Biotech's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmagreen Biotech (Pharmagreen Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmagreen Biotech Inc (OTCPK:PHBI) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

N/A

Address

112 North Curry Street, Carson, NV, USA, 89703

Website

https://www.pharmagreen.ca

Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.